These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12580749)

  • 1. Statistical methods in clinical trials.
    Gebski VJ; Keech AC
    Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 4. [n or more in clinical trials? Zelen's models for randomization].
    Taube A
    Lakartidningen; 1994 Mar; 91(10):977-82. PubMed ID: 8139323
    [No Abstract]   [Full Text] [Related]  

  • 5. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of statistical significance.
    Kane RC
    Oncologist; 2008 Nov; 13(11):1129-33. PubMed ID: 18984874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 9. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
    [No Abstract]   [Full Text] [Related]  

  • 11. Pros and cons of composite endpoints in anesthesia trials.
    Myles PS; Devereaux PJ
    Anesthesiology; 2010 Oct; 113(4):776-8. PubMed ID: 20808209
    [No Abstract]   [Full Text] [Related]  

  • 12. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 13. How to deal with multiple endpoints in clinical trials.
    Neuhäuser M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized clinical trials in surgery: why do we need them?
    Balch CM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):241-2. PubMed ID: 16872941
    [No Abstract]   [Full Text] [Related]  

  • 15. On the evolution of statistical methods as applied to clinical trials.
    Machin D
    J Intern Med; 2004 May; 255(5):521-8. PubMed ID: 15078495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature.
    Scales CD; Norris RD; Preminger GM; Vieweg J; Peterson BL; Dahm P
    J Urol; 2008 Oct; 180(4):1463-7. PubMed ID: 18710745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase II studies and their ethics.
    Abratt RP; Reece WH; Enas NH; Stephens R
    J Clin Oncol; 2005 Dec; 23(36):9443. PubMed ID: 16361651
    [No Abstract]   [Full Text] [Related]  

  • 18. [I. Evaluation of the efficacy of a clinical intervention].
    Epidemiol Prev; 1989; 11(40-41):3-23. PubMed ID: 2534527
    [No Abstract]   [Full Text] [Related]  

  • 19. Trials and tribulations of noninferiority: the ximelagatran experience.
    Albers GW; Diener HC; Frison L; Grind M; Horrow J; Nevinson M; Olsson SB; Partridge S; Petersen P; Vahanian A; Halperin JL;
    J Am Coll Cardiol; 2006 Sep; 48(5):1058; author reply 1059. PubMed ID: 16949503
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients.
    Freidlin B; Simon R
    Clin Cancer Res; 2005 Nov; 11(21):7872-8. PubMed ID: 16278411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.